5 days ago
NVO
AnalystsEvan David SeigermanEvan David Seigerman's Stock Forecasts
AnalystsEvan David Seigerman
Sectors:
Industries:
Analyst Ranking
Top 21%
#1086 out of 5116 analysts
Average Return
+9.35%
Win Rate
53%25 out of 47
Risk vs Reward
Poor
Good
Evan David Seigerman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Candel Therapeutics IncCADL | +568.75% | $1.60 | $10.70 | 2023-05-15 - 2024-05-14 | Buy |
Morphic Holding IncMORF | +147.53% | $22.49 | $55.67 | 2023-09-28 - 2024-07-09 | Buy |
Eli Lilly & CoLLY | +81.93% | $306.82 | $558.19 | 2022-09-06 - 2023-09-05 | Buy |
Merus NvMRUS | +74.36% | $55.14 | $96.14 | 2025-05-23 - 2025-11-28 | Buy |
Acadia Pharmaceuticals IncACAD | +69.99% | $14.73 | $25.04 | 2025-04-17 - 2025-11-28 | Buy |
Evan David Seigerman Analyst Color
Get additional color on Evan David Seigerman's coverage of popular stocks
2 months ago
NVO
7 months ago
NVO
10 months ago
MRK
a year ago
NVO
2 years ago
PFE
Evan David Seigerman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Novo Nordisk A SNVO | 8 | Hold | $46.00 | -6.79% | Maintains | 5 days ago |
Replimune Group IncREPL | 5 | Hold | $11.00 | +10.00% | Upgrades | a month ago |
Abbvie IncABBV | 8 | Buy | $240.00 | +5.40% | Maintains | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 8 | Buy | $640.00 | -17.97% | Maintains | 4 months ago |
Neurogene IncNGNE | 2 | Buy | $26.00 | +23.34% | Maintains | 6 months ago |
Merus NvMRUS | 1 | Buy | $110.00 | +14.42% | Maintains | 6 months ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $28.00 | +11.82% | Maintains | 6 months ago |
Arvinas IncARVN | 1 | Buy | $10.00 | -20.54% | Maintains | 7 months ago |
Merck & Co IncMRK | 4 | Hold | $96.00 | -8.42% | Maintains | 10 months ago |
Amgen IncAMGN | 4 | Buy | $346.00 | +0.16% | Maintains | 10 months ago |
Disc Medicine IncIRON | 1 | Buy | $112.00 | N/A | Maintains | a year ago |
Morphic Holding IncMORF | 3 | Hold | $57.00 | N/A | Downgrades | a year ago |
Structure Therapeutics IncGPCR | 2 | Buy | $100.00 | N/A | Maintains | a year ago |
Pfizer IncPFE | 4 | Buy | $36.00 | N/A | Reiterates | 2 years ago |
Mirati Therapeutics IncMRTX | 4 | Hold | $72.00 | N/A | Maintains | 2 years ago |
Candel Therapeutics IncCADL | 1 | Buy | $3.00 | N/A | Maintains | 3 years ago |
Eli Lilly & CoLLY | 1 | Buy | $396.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.